CagriSema-style escalation starts at 0.25 mg per week with semaglutide and steps up every 4 weeks (0.5, 1.0, 1.7, 2.4 mg) over 16 weeks
As distrust rises, accessibility becomes more and more important
1 mL luer lock syringe Holds 1 mL, marked directly in mL (no unit conversion)
Protocol approach 3: comprehensive repair (thymosin alpha-1 plus BPC-157 plus TB-500) Goal: Immune rebalancing combined with aggressive tissue repair Components: Thymosin alpha-1: 1.6 mg subcutaneously twice per week BPC-157: 250 mcg subcutaneously twice daily near affected tissue TB-500 : 2-5 mg subcutaneously twice per week for loading, then weekly for maintenance Rationale: This three-peptide approach targets immune regulation (TA1), mucosal and tissue healing (BPC-157), and cellular migration plus repair (TB-500)
If youre at risk or have symptoms, talking to a doctor is a big step towards feeling better and living better
Can Barrier publish a percent-release-over-time curve
